Advancing regulatory variant effect prediction with AlphaGenome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41606153.
- Also identified by DOI 10.1038/s41586-025-10014-0 and PMC identifier 12851941.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Deep learning models that predict functional genomic measurements from DNA sequences are powerful tools for deciphering the genetic regulatory code. Existing methods involve a trade-off between input sequence length and prediction resolution, thereby limiting their modality scope and performance<sup>1-5</sup>. We present AlphaGenome, a unified DNA sequence model, which takes as input 1 Mb of DNA sequence and predicts thousands of functional genomic tracks up to single-base-pair resolution across diverse modalities. The modalities include gene expression, transcription initiation, chromatin accessibility, histone modifications, transcription factor binding, chromatin contact maps, splice site usage and splice junction coordinates and strength. Trained on human and mouse genomes, AlphaGenome matches or exceeds the strongest available external models in 25 of 26 evaluations of variant effect prediction. The ability of AlphaGenome to simultaneously score variant effects across all modalities accurately recapitulates the mechanisms of clinically relevant variants near the TAL1 oncogene<sup>6</sup>. To facilitate broader use, we provide tools for making genome track and variant effect predictions from sequence.
Medical subject headings
- Deep Learning
- Genetic Variation
- Genome
- Genome, Human
- Sequence Analysis, DNA